Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Definitive Healthcare (DH) Change in Accured Expenses (2020 - 2025)

Definitive Healthcare (DH) has disclosed Change in Accured Expenses for 6 consecutive years, with -$1.4 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Accured Expenses fell 405.61% year-over-year to -$1.4 million, compared with a TTM value of -$1.1 million through Dec 2025, up 80.07%, and an annual FY2025 reading of -$1.1 million, up 80.07% over the prior year.
  • Change in Accured Expenses was -$1.4 million for Q4 2025 at Definitive Healthcare, down from $12.5 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $12.5 million in Q3 2025 and bottomed at -$8.7 million in Q1 2025.
  • Average Change in Accured Expenses over 5 years is $67300.0, with a median of -$863000.0 recorded in 2024.
  • The sharpest move saw Change in Accured Expenses skyrocketed 469.72% in 2022, then tumbled 405.61% in 2025.
  • Year by year, Change in Accured Expenses stood at $7.4 million in 2021, then crashed by 136.46% to -$2.7 million in 2022, then skyrocketed by 208.35% to $2.9 million in 2023, then tumbled by 109.76% to -$285000.0 in 2024, then crashed by 405.61% to -$1.4 million in 2025.
  • Business Quant data shows Change in Accured Expenses for DH at -$1.4 million in Q4 2025, $12.5 million in Q3 2025, and -$3.4 million in Q2 2025.